申请人:Bayer Aktiengesellschaft
公开号:US05231103A1
公开(公告)日:1993-07-27
The novel quinolin-2-yl-methoxybenzylhydroxyureas can be prepared by reaction of appropriate ketones with hydroxylamine and reduction of the ketoximes and subsequent reaction with isocyanates. The new substances can be employed as active substances in medicaments.
新型的喹啉-2-基甲氧基苯甲基羟基脲类化合物可以通过适当的酮类与羟胺反应,还原酮肟并随后与异氰酸酯反应制备而成。这些新物质可以作为药物中的活性成分。